全文获取类型
收费全文 | 1783篇 |
免费 | 95篇 |
国内免费 | 13篇 |
学科分类
医药卫生 | 1891篇 |
出版年
2024年 | 4篇 |
2023年 | 31篇 |
2022年 | 65篇 |
2021年 | 110篇 |
2020年 | 73篇 |
2019年 | 139篇 |
2018年 | 97篇 |
2017年 | 65篇 |
2016年 | 88篇 |
2015年 | 74篇 |
2014年 | 85篇 |
2013年 | 108篇 |
2012年 | 140篇 |
2011年 | 146篇 |
2010年 | 70篇 |
2009年 | 67篇 |
2008年 | 80篇 |
2007年 | 78篇 |
2006年 | 74篇 |
2005年 | 40篇 |
2004年 | 36篇 |
2003年 | 25篇 |
2002年 | 25篇 |
2001年 | 14篇 |
2000年 | 7篇 |
1999年 | 12篇 |
1998年 | 4篇 |
1997年 | 4篇 |
1996年 | 3篇 |
1995年 | 4篇 |
1994年 | 3篇 |
1993年 | 3篇 |
1992年 | 19篇 |
1991年 | 13篇 |
1990年 | 10篇 |
1989年 | 11篇 |
1988年 | 12篇 |
1987年 | 5篇 |
1986年 | 3篇 |
1985年 | 3篇 |
1984年 | 3篇 |
1983年 | 9篇 |
1982年 | 4篇 |
1981年 | 2篇 |
1979年 | 5篇 |
1975年 | 4篇 |
1974年 | 4篇 |
1971年 | 4篇 |
1967年 | 1篇 |
1965年 | 2篇 |
排序方式: 共有1891条查询结果,搜索用时 0 毫秒
41.
Gerard M O'Reilly Rob D Mitchell Biswadev Mitra Hamed Akhlaghi Viet Tran Jeremy S Furyk Paul Buntine Holly Bannon‐Murphy Timothy Amos Maushmi Udaya Kumar Emma Perkins Alexandra Prentice Olivia Szwarcberg Ashley Loughman Nicole Lowry Steven Colwell Michael P Noonan Ryan Hiller Andrew Paton De Villiers Smit Peter A Cameron 《Emergency medicine Australasia : EMA》2021,33(1):114-124
42.
43.
Quique Bassat Bernhards Ogutu Abdoulaye Djimde Kirstin Stricker Kamal Hamed 《Antimicrobial agents and chemotherapy》2015,59(8):4366-4374
Specially created pediatric formulations have the potential to improve the acceptability, effectiveness, and accuracy of dosing of artemisinin-based combination therapy (ACT) in young children, a patient group that is inherently vulnerable to malaria. Artemether-lumefantrine (AL) Dispersible is a pediatric formulation of AL that is specifically tailored for the treatment of children with uncomplicated Plasmodium falciparum malaria, offering benefits relating to efficacy, convenience and acceptance, accuracy of dosing, safety, sterility, stability, and a pharmacokinetic profile and bioequivalence similar to those of crushed and intact AL tablets. However, despite being the first pediatric antimalarial to meet World Health Organization (WHO) specifications for use in infants and children who are ≥5 kg in body weight and its inclusion in WHO Guidelines, there are few publications that focus on AL Dispersible. Based on a systematic review of the recent literature, this paper provides a comprehensive overview of the clinical experience with AL Dispersible to date. A randomized, phase 3 study that compared the efficacy and safety of AL Dispersible to those of crushed AL tablets in 899 African children reported high PCR-corrected cure rates at day 28 (97.8% and 98.5% for AL Dispersible and crushed tablets, respectively), and the results of several subanalyses of these data indicate that this activity is observed regardless of patient weight, food intake, and maximum plasma concentrations of artemether or its active metabolite, dihydroartemisinin. These and other clinical data support the continued use of pediatric antimalarial formulations in all children <5 years of age with uncomplicated malaria when accompanied by continued monitoring for the emergence of resistance. 相似文献
44.
45.
46.
Abd A. Tahrani Kiran Dubb Neil T. Raymond Safia Begum Quratul A. Altaf Hamed Sadiqi Milan K. Piya Martin J. Stevens 《Diabetologia》2014,57(6):1249-1256
Aims/hypothesis
The aim of this work was to assess the impact of cardiac autonomic neuropathy (CAN) on the development and progression of chronic kidney disease (CKD) in patients with type 2 diabetes.Methods
We conducted a cohort study in adults with type 2 diabetes. Patients with end-stage renal disease were excluded. CKD was defined as the presence of albuminuria (albumin/creatinine ratio GFR >?3.4 mg/mmol) or an estimated (eGFR) <?60 ml min?1 1.73 m?2. CKD progression was based on repeated eGFR measurements and/or the development of albuminuria. CAN was assessed using heart rate variability.Results
Two hundred and four patients were included in the analysis. At baseline, the prevalence of CKD and CAN was 40% and 42%, respectively. Patients with CAN had lower eGFR and higher prevalence of albuminuria and CKD. Spectral analysis variables were independently associated with eGFR, albuminuria and CKD at baseline. After a follow-up of 2.5 years, eGFR declined to a greater extent in patients with CAN than in those without CAN (?9.0?±?17.8% vs ?3.3?±?10.3%, p?=?0.009). After adjustment for baseline eGFR and baseline differences, CAN remained an independent predictor of eGFR decline over the follow-up period (β?=??3.5, p?=?0.03). Spectral analysis variables were also independent predictors of eGFR decline.Conclusions/interpretation
CAN was independently associated with CKD, albuminuria and eGFR in patients with type 2 diabetes. In addition, CAN was an independent predictor of the decline in eGFR over the follow-up period. CAN could be used to identify patients with type 2 diabetes who are at increased risk of rapid decline in eGFR, so that preventative therapies might be intensified. 相似文献47.
48.
49.
Brunner R Aissaoui H Boss C Bozdech Z Brun R Corminboeuf O Delahaye S Fischli C Heidmann B Kaiser M Kamber J Meyer S Papastogiannidis P Siegrist R Voss T Welford R Wittlin S Binkert C 《The Journal of infectious diseases》2012,206(5):735-743
The increasing spread of drug-resistant malaria strains underscores the need for new antimalarial agents with novel modes of action (MOAs). Here, we describe a compound representative of a new class of antimalarials. This molecule, ACT-213615, potently inhibits in vitro erythrocytic growth of all tested Plasmodium falciparum strains, irrespective of their drug resistance properties, with half-maximal inhibitory concentration (IC(50)) values in the low single-digit nanomolar range. Like the clinically used artemisinins, the compound equally and very rapidly affects all 3 asexual erythrocytic parasite stages. In contrast, microarray studies suggest that the MOA of ACT-213615 is different from that of the artemisinins and other known antimalarials. ACT-213615 is orally bioavailable in mice, exhibits activity in the murine Plasmodium berghei model and efficacy comparable to that of the reference drug chloroquine in the recently established P. falciparum SCID mouse model. ACT-213615 represents a new class of potent antimalarials that merits further investigation for its clinical potential. 相似文献
50.
Studer V Bobin J Chahid M Mousavi HS Candes E Dahan M 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(26):E1679-E1687
The mathematical theory of compressed sensing (CS) asserts that one can acquire signals from measurements whose rate is much lower than the total bandwidth. Whereas the CS theory is now well developed, challenges concerning hardware implementations of CS-based acquisition devices--especially in optics--have only started being addressed. This paper presents an implementation of compressive sensing in fluorescence microscopy and its applications to biomedical imaging. Our CS microscope combines a dynamic structured wide-field illumination and a fast and sensitive single-point fluorescence detection to enable reconstructions of images of fluorescent beads, cells, and tissues with undersampling ratios (between the number of pixels and number of measurements) up to 32. We further demonstrate a hyperspectral mode and record images with 128 spectral channels and undersampling ratios up to 64, illustrating the potential benefits of CS acquisition for higher-dimensional signals, which typically exhibits extreme redundancy. Altogether, our results emphasize the interest of CS schemes for acquisition at a significantly reduced rate and point to some remaining challenges for CS fluorescence microscopy. 相似文献